Results 191 to 200 of about 133,417 (336)

Metabolic Response at ¹⁸F-FDG PET/CT as a Prognostic Marker after Induction Chemotherapy or Chemoradiotherapy in Localized Esophageal Squamous Cell Carcinoma. [PDF]

Radiol Imaging Cancer
Jain S.
europepmc   +1 more source

“Close Then Clear” Margins in Transoral Resection of p16+ Oropharyngeal Squamous Cell Carcinoma

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Standard 5‐mm surgical margins in the oropharynx are challenging due to the intimate relationship with neurovascular structures and patient function. De‐escalation of therapy with the acceptance of close surgical margins may improve functional patient outcomes.
Chrisje Den Besten, Kalpesh Hathi, Colin MacKay, Depak Patel, Martin J. Bullock, Matthew H. Rigby, S. Mark Taylor, Jonathan R. Trites, Martin Corsten   +8 more
wiley   +1 more source

Development of a Predictive Model for the Risk of Myelosuppression in Patients With Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy. [PDF]

Clin Med Insights Oncol
Wang RH, Jiang DY, Lu J, Xun LX, Wang F, Shao QQ, Zhang HX.   +6 more
europepmc   +1 more source

Lymph Nodal Yield and Prediction of Mortality in Oral Squamous Cell Carcinoma Patients

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Lymph nodal yield (LNY) is increasingly used in oral squamous cell carcinoma (OSCC) research as a prognostic factor and quality metric but remain to be validated across independent OSCC cohorts. Study design Retrospective cohort study.
Christian Mirian, Lasse Rehné Jensen, Mathias Hald, Davide Mattavelli, Cesare Piazza, Linda Feeley, Patrick Sheahan, Marcel Oehme, Christian Freudlsperger, Julius Moratin, Therese Ovesen   +10 more
wiley   +1 more source

Treatment of high‐risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co‐infusion of T cell‐depleted haematopoietic stem cells and culture‐expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype [PDF]

, 2002
Seung‐Tae Lee, Joon Ho Jang, June‐Won Cheong, Jin Seok Kim, Ho‐Young Maemg, Jee Sook Hahn, Yun Woong Ko, Yoo Hong Min   +7 more
openalex   +1 more source

Bridging the Gap: How Organ‐on‐a‐Chip Technology Facilitates the Battle against Glioma

Small Science, EarlyView.
This review critically evaluates current state‐of‐the‐art in vitro glioma models especially glioma‐on‐a‐chip models based on readout capability, performance, and physiological relevance. It summarizes the key parameters and proposes a practical framework to guide researchers in selecting the most suitable preclinical models for glioma studies.
Su Liu, Zhenyu Gong, Dairan Zhou, Vanesa Ayala‐Nunez, Tao Xu, Peter Wick   +5 more
wiley   +1 more source

Surgery versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced gastrointestinal tract cancers. [PDF]

Front Oncol
Ye X, Wu Z, Teng W, Zhang Y, Chen Y, Sheng L, Lin J, Wang X.   +7 more
europepmc   +1 more source

Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer

, 2001
J I Geh, A. Crellin, Rob Glynne‐Jones
openalex   +1 more source

Does chemoradiotherapy after intended curative surgery increase survival of gastric cancer patients? [PDF]

, 2002
A. Cuschieri
openalex   +1 more source

Pan‐ERBB Inhibitors Synergize With KRAS Inhibitors in Rectal Cancer

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background Emerging RAS inhibitors show promise in treating KRAS‐mutated malignancies, but resistance mechanisms limit their clinical efficacy. Given recent clinical findings associating KRAS mutations with reduced response to neoadjuvant therapy in rectal cancer (RC), we aimed to investigate their impact on treatment outcomes and explore ...
Jonas Buchloh, Melanie Spitzner, Hauke Zimmermann, Xin Fang, Constanza Tapia Contreras, Carolin Schneider, Tiago de Oliveria, Stefan Küffer, Michael Linnebacher, Felix Rühlmann, Lena Conradi, Matthias Wirth, Michael Ghadimi, Marian Grade, Jochen Gaedcke, Günter Schneider   +15 more
wiley   +1 more source